What is the price-to-earnings ratio of Spirox?
The price-earnings ratio of Spirox is currently 8.64.
Spirox P/S 2024
Spirox P/S
8.64
Ticker
3055.TW
ISIN
TW0003055000
As of Nov 4, 2024, Spirox's P/S ratio stood at 8.64, a 226.04% change from the 2.65 P/S ratio recorded in the previous year.
The Spirox P/S history
Spirox Aktienanalyse
What does Spirox do?
The Spirox Corporation is a company that was founded in 2007 and is headquartered in Menlo Park, California. The company operates in the medical technology industry and specializes in the development of products for nasal breathing. The mission of Spirox is to help people who have difficulty breathing through their nose. The company has recognized that many people have difficulty breathing through their nose due to congestion or other issues. Breathing through the mouth, however, can lead to a range of health problems such as dry mouth, sleep apnea, and respiratory infections. Therefore, Spirox has set out to develop innovative solutions to facilitate nasal breathing. Spirox's products include both implantable and non-implantable solutions. The company has a small but effective product portfolio consisting of two products: the Latera Nasal Stent and the AeroForm Nasal Stent. The Latera Nasal Stent is used to permanently open the nasal passages and facilitate breathing. The placement of the stent is a minimally invasive procedure that is typically performed on an outpatient basis. The Latera Nasal Stent is inserted and secured in the nasal wings to allow for better airflow through the nostrils. The stent is made of polydioxanone (PDO), a biocompatible polymer fiber that is absorbed by the body. Spirox's second product, the AeroForm Nasal Stent, is a non-implantable nasal stent used for temporary relief of nasal breathing. The AeroForm is a soft stent made of a flexible polymer material. It is inserted into the nasal passages and forms a gentle expansion to facilitate nasal breathing. As a company, Spirox focuses on collaboration with specialists and clinics to ensure that their products have high success rates. The company has established a partnership with the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) to advance scientific research and development in the nasal breathing industry. Spirox is led by experienced executives from the medical technology industry. The CEO, Duke Rohlen, has over 20 years of experience in leading medical technology companies such as Inspire Medical Systems and CV Ingenuity. The board team also includes Elektra Papadopoulos as Chair of the Board, who has worked at Hologic and Boston Scientific, among others. Although Spirox is a relatively small company, it has already received several awards. In 2017, the company was awarded the Red Herring Top 100 North America Award, which recognizes companies that are leading in the innovation industry. Overall, Spirox is an emerging company in the medical technology industry that offers innovative solutions to facilitate nasal breathing. Through collaboration with doctors and clinics and a focus on scientific research, the company aims to improve the success and effectiveness of its products. Spirox ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Spirox's P/S Ratio
Spirox's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Spirox's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Spirox's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Spirox’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Spirox stock
How has the price-earnings ratio of Spirox changed compared to last year?
The price-to-earnings ratio of Spirox has increased by 226.04% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Spirox high compared to other companies?
Yes, the price-to-earnings ratio of Spirox is high compared to other companies.
How does an increase in the price-earnings ratio of Spirox affect the company?
An increase in the price-earnings ratio of Spirox would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Spirox affect the company?
A decrease in the price-earnings ratio of Spirox would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Spirox?
Some factors that influence the price-earnings ratio of Spirox are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Spirox pay?
Over the past 12 months, Spirox paid a dividend of 1 TWD . This corresponds to a dividend yield of about 1.34 %. For the coming 12 months, Spirox is expected to pay a dividend of 0.87 TWD.
What is the dividend yield of Spirox?
The current dividend yield of Spirox is 1.34 %.
When does Spirox pay dividends?
Spirox pays a quarterly dividend. This is distributed in the months of October, August, August, August.
How secure is the dividend of Spirox?
Spirox paid dividends every year for the past 0 years.
What is the dividend of Spirox?
For the upcoming 12 months, dividends amounting to 0.87 TWD are expected. This corresponds to a dividend yield of 1.16 %.
In which sector is Spirox located?
Spirox is assigned to the 'Information technology' sector.
Wann musste ich die Aktien von Spirox kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Spirox from 8/6/2024 amounting to 1.011 TWD, you needed to have the stock in your portfolio before the ex-date on 7/5/2024.
When did Spirox pay the last dividend?
The last dividend was paid out on 8/6/2024.
What was the dividend of Spirox in the year 2023?
In the year 2023, Spirox distributed 0.2 TWD as dividends.
In which currency does Spirox pay out the dividend?
The dividends of Spirox are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Spirox
Our stock analysis for Spirox Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spirox Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.